Recent Finacing
Recent Raise
AuraSense Therapeutics develops Spherical Nucleic Acid (SNA) therapeutics enabling carrier-free intracellular delivery of nucleic-acid payloads for gene regulation and immune modulation across oncology, dermatology, neurology, and immune disorders.
